Lack of Leadership<br />By Rev Shark<br />RealMoney.com Contributor<br />2/13/2009 8:43 AM EST <br /><br />Leadership is a matter of having people look at you and gain confidence, seeing how you react. If you're in control, they're in control. <br />-- Tom Landry<br /><br />Despite all the government action, economic news and loud debates, the key to this market is one rather simple thing: Investors have little confidence. You can see this in the sentiment, the reaction to news and in the charts. <br /><br />Considering that we hear stories every day confirming that this is the worst economic crisis since the Great Depression, it would be surprising if market players were feeling fat and happy. We are unlikely to see the sort of confidence that flourishes in a bull market for a while, but what we might see -- and what we have to watch for -- is greater hope that some of these government moves may be meaningful. <br /><br />Even if you have little confidence in the bank bailouts and stimulus spending, as I do, they can still have a positive impact on the market for a period of time by affecting the mood of the market. We don't even need any real belief in the merits of these plays. We just need to have folks believe there are others who do. After the ugly downside action we have had, no one wants to be left behind when we finally do see better action, so a little spark of confidence can get things moving if the news flow improves and a small group of people start to believe that something substantive is really being done on the economic front. <br /><br />As always, we need to let the market be our guide. The huge late-day reversal yesterday on news of a housing bailout plan pulled us back from some technical danger. The S&P 500 was looking set to close below a key technical line that connected the bottoms in November, January and February, but the index recovered just in the nick of time. A one-day reversal like that is a positive, but we are still just barely hanging onto these support levels. There is no good upside momentum, and charts of individual stocks are not very interesting. <br /><br />I harp on this quite often because it is so important: We need leadership. Some of the big-cap technology stocks like Apple (AAPL) , Google (GOOG) and Baidu (BIDU) have been acting a bit better, but there aren't any pockets of momentum out there. It is when those pockets start to spread to other sectors of the market that we see good, solid, lasting uptrends build. So far, there is no sign of that happening, which means we have to stick to the daytrading if we want to play. If you are longer term, there still is little reason to be jumping in here. <br /><br />We have a mild start this morning as investors contemplate this new mortgage plan but also struggle with more and more poor economic news and worries about banks. I'm looking for a choppy but relatively quiet day compared to yesterday. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: CSTR +12.6%, VCLK +10.7%, RACK +9.5% (also announces $40 mln stock repurchase program), CTSH +8.3%, WYN +7.4% (also discloses that it will initiate $200 mln equity sales program), ANF +4.4%, MFE +2.8%, ENB +2.3%, SONO +2.0%, E +1.7%, PEP +1.5%... Other news: MELA +104.0% (announces positive top-line results form MelaFind trial), YRCW +9.1% (finalizes bank amendment), SIRF +7.3% (still checking), JASO +5.9% (announces update on strategic alliance with BP Solar), LVS +5.2% (modestly rebounding from yesterday's 15% drop)... Analyst comments: DFT +6.4% (upgraded to Buy at BofA/Merrill), SIGM +5.9% (upgraded to Outperform at Baird), STM +4.4%, WFR +2.7% and TXN +1.8% (upgraded to Neutral at UBS), PFCB +3.5% (upgraded to Outperform at William Blair), PALM +2.9% (initiated with Outperform and $11 tgt at Credit Suisse), ASML +2.8% (upgraded to Buy at Deutsche), V +2.0% and MA +1.4% (upgraded to Outperform from Underperform at Cowen), MRVL +1.5% (initiated with a Buy at ThinkEquity- tgt $10).<br /><br />Allapoole avanevad:<br /><br />Gapping downIn reaction to disappointing earnings/guidance: LYG -31.3% (sees adjusted pretax profit of GBP1.3 bln; sees core Tier 1 Capital ratio 6-6.5% at Dec 31 - DJ), AMKR -9.4% (light volume), CAKE -7.1% (also downgraded to Sell from Neutral at Piper Jaffray), COGO -6.0% (also downgraded to Neutral from Positive at Susquehanna Financial), COG -5.3%, PNRA -3.7%, SHO -3.1%... Select financials under pressure: RBS -12.7%, AIB -12.1%, FITB -6.8%, HBAN -5.5%, MTU -3.7%, BAC -3.6% (downgraded to Hold at Argus), JPM -3.3%, WFC -3.2% (announces 4th quarter 2008 non-cash charge for preferred securities), UBS -2.3%, HBC -2.1%, MS -1.7%, GS -1.4%... Select stem cell related names trading lower: GERN -12.5% (filed an 8-K discussing a European patent decision from November; also chatter of a spot secondary offering being priced below current levels), ASTM -5.8%, STEM -3.4%... Select metals/mining names showing weakness: GOLD -4.0%, AAUK -3.6%, AU -2.6%, AUY -2.1%, ABX -1.7%, GLD -1.2%... Other news: SVNT -28.2% (announced that the co filed amendments to strengthen and clarify the data included in the previously submitted pegloticase Biologics License Application), JAH -7.5% (still checking), ITMN -6.5% (prices common stock offering - 3.5 mln shares at $17.96), CAL -5.1% (still checking), PVX -4.9% (reduces cash distribution to $0.06 per unit from $0.09 per unit; lowers capital budget), AAV -4.9% (approves reduction in the cash distribution for the month of February 2009 to $0.04 per Unit from the current $0.08 per Unit), LPHI -4.6% (Cramer makes negative comments on MadMoney), MDT -1.8% (Judge failed to disclose son's tie to MDT - WSJ)... Analyst comments: EGLE -5.8% (downgraded to Sell at Cantor Fitzgerald), JAVA -5.6% (added to Americas Conviction Sell list at Goldman- Reuters), BWA -4.0% (downgraded to Underperform at Baird), LNCR -3.0% (downgraded to Sell at UBS), NVDA -1.3% (downgraded to Neutral from Buy at Goldman- Reuters), RIMM -1.2% (downgraded to underperform at Credit Suisse).